Gene-environment interaction and the GNB3 gene in the Atherosclerosis Risk in Communities Study

International Journal of Obesity

Volumn 31, Issue 6, 2007, Pages 919-926

  Grove, M L ^a   Morrison, A ^a   Folsom, A R ^b   Boerwinkle, E ^a,c   Hoelscher, D M ^a   Bray, M S ^d  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Genetics; Hypertension; Physical activity; Risk; Variation

Indexed keywords

G PROTEIN BETA 3; GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AFRICAN AMERICANS; AGED; ATHEROSCLEROSIS; COHORT STUDIES; EXERCISE; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; PREVALENCE; PROTEIN SUBUNITS; RISK FACTORS; UNITED STATES;

EID: 34249714817     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803545     Document Type: Article

References (54)

1. McGinnis J, Foege W. Actual causes of death in the United States. JAMA 1993; 270: 2207-2212.
2. Siffert W, Naber C, Walla M, Ritz E. G protein β3 subunit 825T allele and its potential association with obesity in hypertensive individuals. J Hypertens 1999; 17: 1095-1098.
3. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R et al. Association of a human G-protein β3 subunit variant with hypertension. Nat Genet 1998; 18: 45-48.
4. Siffert W. G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu Rev Med 2005; 56: 17-28.
5. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) study: Design and objectives. Am J Epidemiol 1989; 129: 687-702.
6. World Health Organization. Physical status: the use and interpretation of anthropometry. WHO: Geneva, 1995.
7. Pickering TG, Gerin W, Schwartz AR. What is the white-coat effect and how should it be measured? Blood Press Monit 2002; 7: 293-300.
8. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Gattobigio R et al. White coat hypertension and white coat effect similarities and differences. Am J Hypertens 1995; 8: 790-798.
9. Staessen J, O'Brien E, Atkins N, Amery A. Short report: ambulatory blood pressure in normotensive compared with hypertensive subjects. The Ad-Hoc Working Group. J Hypertens 1993; 11: 1289-1297.
10. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
11. Folsom AR, Arnett DK, Hutchinson RG, Liao F, Clegg LX, Cooper LS. Physical activity and incidence of coronary heart disease in middle-aged women and men. Med Sci Sports Exerc 1997; 29: 901-909.
12. Baecke J, Burema J, Frijters J. A short questionnaire for the measurement of habitual physical activity in epidemiologic studies. Am J Clin Nutr 1982; 36: 936-942.
13. Rosskopf D, Dusing R, Siffert W. Membrane sodium-proton exchange and primary hypertension. Hypertension 1993; 21: 607-617.
14. Siffert W, Dusing R. Sodium-proton exchange and primary hypertension. Hypertension 1995; 26: 649-655.
15. Rosskopf D, Manthey I, Habich C, Kielbik M, Eisenhardt A, Nikula C et al. Identification and characterization of Gβ3s2, a novel splice variant of the G-protein β3 subunit. Biochem J 2003; 371: 223-232.
16. Rosskopf D, Koch K, Habich C, Geerdes J, Ludwig A, Wilhelms S et al. Interaction of Gβ3 s, a splice variant of the G-protein Gβ3, with Gγ- and Gα-proteins. Cell Signal 2003; 15: 479-488.
17. 3 polymorphism on adrenoceptor-mediated lipolysis in human fat cells. Diabetes 2002; 51: 1601-1608.
18. Ruiz-Velasco V, Ikeda SR. A splice variant of the G protein β3-subunit implicated in disease states does not modulate ion channels. Physiol Genomics 2003; 13: 85-95.
19. Lodish H, Berk A, Zipursky LS, Matsudaira P, Baltimore D, Darnell J. Cell-to-cell signaling: hormones and receptors. In: Tenney S (eds) Molecular Cell Biology. W H Freeman: New York, 2000.
20. Hauner H, Rohrig K, Siffert W. Effects of the G-protein β3 subunit 825T allele on adipogenesis and lipolysis in cultured human preadipocytes and adipocytes. Horm Metab Res 2002; 34: 475-480.
21. Siffert W, Forster P, Jockel KH, Mvere DA, Brinkmann B, Naber C et al. Worldwide ethnic distribution of the G protein β3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and black African individuals. J Am Soc Nephrol 1999; 10: 1921-1930.
22. Hegele RA, Anderson C, Young TK, Connelly PW. G-protein β3 subunit gene splice variant and body fat distribution in Nunavut Inuit. Genome Res 1999; 9: 972-977.
23. Ohshiro Y, Ueda K, Wakasaki H, Takasu N, Nanjo K. Analysis of 825C/T polymorphism of G proteinβ3 subunit in obese/diabetic Japanese. Biochem Biophys Res Commun 2001; 286: 678-680.
24. Suwazono Y, Okubo Y, Kobayashi E, Miura K, Morikawa Y, Ishizaki M et al. Lack of association between human G-protein β3 subunit variant and overweight in Japanese workers. Obes Res 2004; 12: 4-8.
25. Benjafield AV, Lin RC, Dalziel B, Gosby AK, Caterson ID, Morris BJ. G-protein β3 subunit gene splice variant in obesity and overweight. Int J Obes Relat Metab Disord 2001; 25: 777-780.
26. Terra SG, McGorray SP, Wu R, McNamara DM, Cavallari LH, Walker JR et al. Association between β-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study. Int J Obes 2005; 29: 746-754.
27. Hinney A, Geller F, Neupert T, Sommerlad C, Gerber G, Gorg T et al. No evidence for involvement of alleles of the 825-C/T polymorphism of the G-protein subunit β3 in body weight regulation. Exp Clin Endocrinol Diabetes 2001; 109: 402-405.
28. Gutersohn A, Naber C, Muller N, Erbel R, Siffert W. G protein β3 subunit 825 TT genotype and post-pregnancy weight retention. Lancet 2000; 355: 1240-1241.
29. Rankinen T, Rice T, Leon AS, Skinner JS, Wilmore JH, Rao DC et al. G protein β3 polymorphism and hemodynamic and body composition phenotypes in the HERITAGE Family Study. Physiol Genomics 2002; 8: 151-157.
30. Poston WS, Haddock CK, Spertus J, Calanese EM, Pavlik VN, Hyman DJ et al. Physical activity does not mitigate G-proteinrelated genetic risk for obesity in individuals of African descent. Eat Weight Disord 2002; 7: 68-71.
31. Schunkert H, Hense HW, Doring A, Riegger GA, Siffert W. Association between a polymorphism in the G protein β3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 1998; 32: 510-513.
32. Hengstenberg C, Schunkert H, Mayer B, Doring A, Lowel H, Hense HW et al. Association between a polymorphism in the G protein β3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Cardiovasc Res 2001; 49: 820-827.
33. Beige J, Hohenbleicher H, Distler A, Sharma AM. G-protein beta3 subunit C825T variant and ambulatory blood pressure in essential hypertension. Hypertension 1999; 33: 1049-1051.
34. Benjafield A, Jeyasingam C, Nyholt D, Griffiths L, Morris B. Gprotein β3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension 1998; 32: 1094-1097.
35. Brand E, Wang J-G, Herrmann S-M, Staessen JA. An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gβ3 C825T polymorphism. J Hypertens 2003; 21: 729-737.
36. Hegele R, Harris S, Hanley A, Cao H, Zinman B. G protein β3 subunit gene variant and blood pressure variation in Canadian Oji-Cree. Hypertension 1998; 32: 688-692.
37. Dai S, Shi J, Ding Q, Wang H, Dong L, Sun D et al. Polymorphism analysis of 825C/T of the G-protein beta 3 subunit in high risk population of hypertension in the northeast China. Yi Chuan Xue Bao 2002; 29: 294-298.
38. Kato N, Sugiyama T, Morita H, Kurihara H, Yamori Y, Yazaki Y. G protein beta 3 subunit variant and essential hypertension in Japanese. Hypertension 1998; 32: 935-938.
39. Shioji K, Kokubo Y, Mannami T, Inamoto N, Morisaki H, Mino Y et al. Association between hypertension and the alpha-adducin, beta1-adrenoreceptor, and G-protein beta3 subunit genes in the Japanese population; the Suita study. Hypertens Res 2004; 27: 31-37.
40. Ishikawa K, Imai Y, Katsuya T, Ohkubo T, Tsuji I, Nagai K et al. Human G-protein beta3 subunit variant is associated with serum potassium and total cholesterol levels but not with blood pressure. Am J Hypertens 2000; 13: 140-145.
41. Snapir A, Heinonen P, Tuomainen T-P, Lakka TA, Kauhanen J, Salonen JT et al. G-protein β3 subunit C825T polymorphism: no association with risk for hypertension and obesity. J Hypertens 2001; 19: 2149-2155.
42. Dong Y, Zhu H, Sagnella GA, Carter ND, Cook DG, Cappuccio FP. Association between the C825T polymorphism of the G protein β3-subunit gene and hypertension in blacks. Hypertension 1999; 34: 1193-1196.
43. Larson N, Hutchinson R, Boerwinkle E. Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension 2000; 35: 1297-1300.
44. Mahmood M, Mian Z, Afzal A, Frossard P. G-protein beta-3 subunit gene 825C>T dimorphism is associated with left ventricular hypertrophy but not essential hypertension. Med Sci Monit 2005; 11: CR6-CR9.
45. Huang X, Ju Z, Song Y, Zhang H, Sun K, Lu H et al. Lack of association between the G protein β3 subunit gene and essential hypertension in Chinese: a case-control and a family-based study. J Mol Med 2003; 81: 729-735.
46. Wang H, Sun N, Gao Y, Gou S. G protein beta 3 subunit C825T polymorphism and essential hypertension in Chinese. Beijing Da Xue Xue Bao 2003; 35: 423-425.
47. Wang X, Wang S, Lin R, Jiang X, Cheng Z, Turdi J et al. GNB3 gene C825T and ACE gene I/D polymorphisms in essential hypertension in a Kazakh genetic isolate. J Hum Hypertens 2004; 18: 663-668.
48. Weinberger M, Fineberg N. Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension 1991; 18: 67-71.
49. Siffert W. Molecular genetics of G proteins and atherosclerosis risk. Basic Res Cardiol 2001; 96: 606-611.
50. Pollex RL, Hanley AJG, Zinman B, Harris SB, Khan HMR, Hegele RA. Metabolic syndrome in aboriginal Canadians: Prevalence and genetic associations. Atherosclerosis 2006; 184: 121-129.
51. Pollex RL, Hanley AJG, Zinman B, Harris SB, Hegele RA. Clinical and genetic associations with hypertriglyceridemic waist in a Canadian aboriginal population. Int J Obes 2006; 30: 484-491.
52. Andersen G, Overgaard J, Albrechtsen A, Glümer C, Borch-Johnsen K, Jørgensen T, et al. Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes. Diabetologia 2006; 49: 75-82.
53. Pols MA, Peeters PH, Bueno-De-Mesquita HB, Ocke MC, Wentink CA, Kemper HC et al. Validity and repeatability of a modified Baecke questionnaire on physical activity. Int J Epidemiol 1995; 24: 381-388.
54. Richardson M, Ainsworth B, Wu H, Jacobs DJ, Leon A. Ability of the Atherosclerosis Risk in Communities (ARIC) Baecke questionnaire to assess leisure-time physical activity. Int J Epidemiol 1995; 24: 685-693.